Kumar Pankaj, Ganure Ashok Laxmanrao, Subudhi Bharat Bhushan, Shukla Shubhanjali
School of Pharmaceutical Sciences, Siksha O Anusandhan University, Bhubaneswar, 751030, India,
Drug Deliv Transl Res. 2015 Jun;5(3):243-56. doi: 10.1007/s13346-015-0221-7.
In the present study, novel hydrogels were prepared through graft copolymerization of methyl methacrylate onto starch and hydroxypropylated starch for intestinal drug delivery. The successful grafting has been confirmed by FTIR, NMR spectroscopy, and elemental analysis. Morphological examination of copolymeric hydrogels by scanning electron microscopy (SEM) confirms the macroporous nature of the copolymers. The high decomposition temperature was observed in thermograms indicating the thermal stability of the hydrogels. To attain a hydrogel with maximum percent graft yield, the impact of reaction variables like concentration of ceric ammonium nitrate as initiator and methyl methacrylate as monomer were consistently optimized. X-ray powder diffraction and differential scanning calorimetric analysis supported the successful entrapment of the drug moiety (esomeprazole magnesium; proton pump inhibitor) within the hydrogel network. Drug encapsulation efficiency of optimized hydrogels was found to be >78%. Furthermore, swelling capacity of copolymeric hydrogels exhibited a pH-responsive behavior which makes the synthesized hydrogels potential candidates for controlled delivery of medicinal agents. In vitro drug release was found to be sustained up to 14 h with 80-90% drug release in pH 6.8 solution; however, the cumulative release was 40-45% in pH 1.2. The gastrointestinal transit behavior of optimized hydrogel was determined by gamma scintigraphy, using (99m)Tc as marker. The amount of radioactive tracer released from the labeled hydrogel was minimal when the hydrogel was in the stomach, whereas it increased as hydrogel reached in intestine. Well-correlated results of in vitro and in vivo analysis proved their controlled release behavior with preferential delivery into alkaline pH environment.
在本研究中,通过甲基丙烯酸甲酯在淀粉和羟丙基化淀粉上的接枝共聚制备了新型水凝胶用于肠道药物递送。傅里叶变换红外光谱(FTIR)、核磁共振光谱(NMR)和元素分析证实了接枝成功。通过扫描电子显微镜(SEM)对共聚水凝胶进行形态学检查,证实了共聚物的大孔性质。热重分析曲线显示出较高的分解温度,表明水凝胶具有热稳定性。为了获得具有最大接枝率的水凝胶,对诸如硝酸铈铵作为引发剂和甲基丙烯酸甲酯作为单体的反应变量的影响进行了持续优化。X射线粉末衍射和差示扫描量热分析支持药物部分(埃索美拉唑镁;质子泵抑制剂)成功包封在水凝胶网络中。优化后的水凝胶的药物包封率>78%。此外,共聚水凝胶的溶胀能力表现出pH响应行为,这使得合成的水凝胶成为药物控释的潜在候选物。体外药物释放可持续长达14小时,在pH 6.8溶液中的药物释放率为80 - 90%;然而,在pH 1.2时的累积释放率为40 - 45%。使用(99m)Tc作为标记物,通过γ闪烁显像法测定了优化水凝胶的胃肠道转运行为。当水凝胶在胃中时,从标记水凝胶中释放的放射性示踪剂的量最小,而当水凝胶到达肠道时,其释放量增加。体外和体内分析结果具有良好的相关性,证明了它们的控释行为以及优先递送至碱性pH环境的特性。